What are GLP-1 therapies?
GLP-1 therapies are a class of medicines that help lower blood sugar, support weight loss, reduce the risk of heart and kidney complications, and can even lower the risk of early death in people with type 2 diabetes. These must be prescribed by your health care specialist and require close follow-ups. People living with obesity, […]
Expanded Medicare Coverage Could Bring GLP-1s to Millions
The federal government negotiated with drug makers to bring lower prices on GLP-1 drugs to millions of Medicare patients. Medscape Medical News
FTSE 100 vs S&P 500: here’s how £10k invested at the start of the year compares
It’s been a volatile year in stock markets around the world. From tariff scares through to monetary policy shifts, investors have been left trying to dodge market corrections and carefully navigate which stocks to buy and which to avoid. But if an investor had decided to park £10k in a tracker fund of either the […]
Eli Lilly reduces Zepbound price
Eli Lilly has lowered the price of its GLP-1 drug Zepbound (tirzepatide) in single-dose vials, with the starting dose now available for $299 per month through the company’s direct-to-consumer platform, LillyDirect. The drugmaker said in a Dec. 1 news release the price cut is part of a broader effort to reduce out-of-pocket costs and expand […]
Warning over weight loss jab shortage as obesity set to double by 2030
GLP-1 medication, such as Wegovy, was added to the list of ‘essential’ medicines by the World Health Organization in September
World Health Organization recommends GLP-1 drugs for weight management
The World Health Organization on Monday recommended GLP-1 drugs for adult weight management.
World Health Organization recommends GLP-1 drugs for obesity
World Health Organization recommends use of GLP-1 drugs for obesity
On next-gen GLP-1 drugs. “A mere decade ago, obesity drugs powerful enough…
On next-gen GLP-1 drugs. “A mere decade ago, obesity drugs powerful enough for people to routinely drop double-digit percentages of their body weight were unheard-of. Today, there are two, and they feel ubiquitous.” 💬 Join the discussion on kottke.org →
Lilly slightly lowers self-pay prices for single-dose vials of Zepbound
Eli Lilly will shave $50 off the self-pay price for most single-dose vials of its blockbuster weight loss drug Zepbound, about a month after agreeing to lower the prices for its multi-dose pens as part …